Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences

RTTNews | 839 hari yang lalu
Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences

(RTTNews) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical company focused exclusively on Women's Health.

Lupin's U.S. Commercial Women's Health Specialty Business is primarily focused on commercializing SOLOSEC (secnidazole) 2g oral granules.

This FDA-approved single-dose antimicrobial agent provides a complete course of therapy for the treatment of bacterial vaginosis (BV) and trichomoniasis, two common sexual health infections.

baca selengkapnya
Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences Names Albert Altro As Interim CFO

Evofem Biosciences, Inc. (EVFM) announced Thursday the appointment of Albert Altro as Interim Chief Financial Officer of the Company. He replaces Jay File, who is leaving the Company to explore other opportunities.
RTTNews | 1333 hari yang lalu
Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved  In Nigeria

Evofem Biosciences Says Vaginal Contraceptive Gel Phexxi Approved In Nigeria

Evofem Biosciences, Inc. (EVFM) announced Thursday that its hormone-free contraceptive vaginal gel Phexxi has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). This is the first regulatory approval outside the U.S.
RTTNews | 1487 hari yang lalu
Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Inks Deal With Pharmacy Benefit Managers In The U.S. For Access To Phexxi

Evofem Biosciences, Inc. (EVFM) announced Tuesday it has reached an agreement with one of the nation's largest pharmacy benefit managers (PBMs) to ensure most women covered by this plan can fill their Phexxi prescriptions for pregnancy prevention, without restrictions such as prior authorization or step therapy. Phexxi is an on-demand method of birth control used to prevent pregnancy.
RTTNews | 1587 hari yang lalu
Swiss Market Ends Modestly Higher

Swiss Market Ends Modestly Higher

The Switzerland market's benchmark SMI ended modestly higher on Friday after holding firm throughout the trading session, outperforming most of its peers in Europe.
RTTNews | 1 hari yang lalu
Major European Markets End Mixed As Investors React To Earnings, Economic Data

Major European Markets End Mixed As Investors React To Earnings, Economic Data

The major European markets closed mixed on Friday even as most of the other markets across the continent ended notably lower, as investors reacted to a slew of corporate earnings announcements and the latest batch of regional economic data. Higher oil prices and weakness in the tech sector due to renewed uncertainty about returns on AI-related investments hurt sentiment.
RTTNews | 1 hari yang lalu
Chicago Business Barometer Pulls Back But Still Indicates Growth In October

Chicago Business Barometer Pulls Back But Still Indicates Growth In October

Growth in Chicago-area business activity slowed moderately in the month of October, according to a report released by MNI Indicators on Friday. The report said the Chicago business barometer fell to 55.3 in October after spiking to 58.8 in September, although a reading above 50 still indicates growth. Economists had expected the business barometer to pull back to 56.0.
RTTNews | 1 hari yang lalu